Press Releases
Feb. 11, 2026
South Korea Sees Increase in Employment Figures
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
5 hours ago
Recyclable Thermoform Blister Packaging Market Volume and Pricing Data 2026-35
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Nxera Pharma Proposes Changes to its Board of Directors
Indeterminate
GlobeNewswire, Inc.
Feb. 13, 2026
Expanding Role of Wound Care Devices Market with USD 3.64 Billion in 2026 in Modern Medicine
Indeterminate
GlobeNewswire, Inc.
Feb. 7, 2026
South Korea Records 8th Swine Fever Case
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Feb. 8, 2026
South Korea Reports Eighth African Swine Fever Case, Orders Culling
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Feb. 13, 2026
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
Indeterminate
GlobeNewswire, Inc.
7 hours ago
Bioengineering Market Size Worth USD 1,484.98 Billion by 2035 Driven by AI-Powered Drug Discovery and Gene Editing
Indeterminate
GlobeNewswire, Inc.
7 hours ago
Why Invest in the Breast Cancer Market Now? USD 40.11 Bn Growth Signals Major Opportunity by 2035
Indeterminate
GlobeNewswire, Inc.
4 hours ago
Nafion Market Size to Worth USD 4.20 Billion by 2035 - Exclusive Report by Towards Chemical and Materials
Indeterminate
GlobeNewswire, Inc.
6 hours ago
High-Quality Rigid Packaging Materials Market Volume and Pricing Data 2026-35
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Building a Healthier Tomorrow: Women’s Digital Health Grows at 20.54% CAGR by 2034
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
Indeterminate
GlobeNewswire, Inc.
Feb. 12, 2026
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company
Indeterminate
GlobeNewswire, Inc.